Intriguingly, a recent study highlighted the important role of IGF2BP1 in m6A-mediated PEG10 upregulation in endometrial cancer [43], reinforcing evidence for the m6A-IGF2BPs-PEG10 regulatory axis identified in our study. This evidence concerns the gene IGF2BP1 and endometrial cancer.